Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
August 2011 Vol 4, No 4, Special Issue
Economic Recession Affects Rates of Cancer Incidence and Treatment
Wayne Kuznar
Read More
Value of Targeted Therapies in Patients Lacking a Molecular Target Questioned
Caroline Helwick
Read More
Most End-of-Life Costs for Patients with Cancer Are Not Drug-Related
Read More
Bankruptcy Rates Markedly Greater for Cancer Survivors
Read More
Inappropriate Antineoplastic Agents Use for Metastatic Cancer Costs Insurers Millions
Read More
Multiple Myeloma
Multiple Myeloma Treatments Are Moving Rapidly from Bench to Bedside
Wayne Kuznar
Read More
Payers' Perspectives
What Do Payers Want in Oncology Diagnostics? Insights from a National Survey of Top Commercial and Medicare Health Plans
Gene Trogan, PhD
Read More
Clinical
New Standard of Care for Childhood Neuroblastoma
Read More
Assay Can Streamline Use of Temozolomide in Glioblastoma
Read More
Clinical
JAK Inhibitor Improves Response, Symptoms in Patients with High-Risk Myelofibrosis
Read More
1
2
3
Page 1 of 3
Results 1 - 10 of 30